Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sho Ikeda

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Cureus|January 15, 2024
Ponatinib Improved the Prognosis of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Japanese Single-Center Cohort StudyNagi Tozawa, Takaya Yamashita, Miho Nara, et al.
Blood|January 4, 2014
MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphomaMitsugu Ito, Kazuaki Teshima, Sho Ikeda, et al.
Therapeutic Drug Monitoring|March 2, 2018
Phase II Clinical Trial of Lenalidomide and Dexamethasone Therapy in Japanese Elderly Patients With Newly Diagnosed Multiple Myeloma to Determine Optimal Plasma Concentration of LenalidomideTakahiro Kobayashi, Masatomo Miura, Takenori Niioka, et al.
British Journal of Haematology|April 22, 2025
Multiple myeloma with 1q gain/amplification exhibits reduced CD38 expression via interleukin-6 receptor overexpressionWataru Kuroki, Akihiro Kitadate, Yuto Takahashi, et al.
Cancer Science|July 21, 2021
Multiple myeloma with t(11;14)-associated immature phenotype has lower CD38 expression and higher BCL2 dependenceAkihiro Kitadate, Toshiki Terao, Kentaro Narita, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2019
Low hexokinase-2 expression-associated false-negative <sup>18</sup>F-FDG PET/CT as a potential prognostic predictor in patients with multiple myelomaYoshiaki Abe, Sho Ikeda, Akihiro Kitadate, et al.
Oncotarget|January 21, 2016
Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphomaSho Ikeda, Akihiro Kitadate, Mitsugu Ito, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 4, 2024
[Successful cord blood transplantation for refractory gamma-delta hepatosplenic T-cell lymphoma developed during treatment of Crohn's disease]Akihito Saito, Miho Nara, Takashi Fujishima, et al.
Cancer Science|November 14, 2025
NF-κB Is a Potential Therapeutic Target for Histone Deacetylase Inhibitor-Resistant Cutaneous T-Cell LymphomaYuto Takahashi, Akihiro Kitadate, Sayaka Iwama, et al.
Oncotarget|December 10, 2016
Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphomaFumito Abe, Akihiro Kitadate, Sho Ikeda, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Cureus|January 15, 2024
Ponatinib Improved the Prognosis of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Japanese Single-Center Cohort StudyNagi Tozawa, Takaya Yamashita, Miho Nara, et al.
Blood|January 4, 2014
MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphomaMitsugu Ito, Kazuaki Teshima, Sho Ikeda, et al.
Therapeutic Drug Monitoring|March 2, 2018
Phase II Clinical Trial of Lenalidomide and Dexamethasone Therapy in Japanese Elderly Patients With Newly Diagnosed Multiple Myeloma to Determine Optimal Plasma Concentration of LenalidomideTakahiro Kobayashi, Masatomo Miura, Takenori Niioka, et al.
British Journal of Haematology|April 22, 2025
Multiple myeloma with 1q gain/amplification exhibits reduced CD38 expression via interleukin-6 receptor overexpressionWataru Kuroki, Akihiro Kitadate, Yuto Takahashi, et al.
Cancer Science|July 21, 2021
Multiple myeloma with t(11;14)-associated immature phenotype has lower CD38 expression and higher BCL2 dependenceAkihiro Kitadate, Toshiki Terao, Kentaro Narita, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2019
Low hexokinase-2 expression-associated false-negative <sup>18</sup>F-FDG PET/CT as a potential prognostic predictor in patients with multiple myelomaYoshiaki Abe, Sho Ikeda, Akihiro Kitadate, et al.
Oncotarget|January 21, 2016
Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphomaSho Ikeda, Akihiro Kitadate, Mitsugu Ito, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 4, 2024
[Successful cord blood transplantation for refractory gamma-delta hepatosplenic T-cell lymphoma developed during treatment of Crohn's disease]Akihito Saito, Miho Nara, Takashi Fujishima, et al.
Cancer Science|November 14, 2025
NF-κB Is a Potential Therapeutic Target for Histone Deacetylase Inhibitor-Resistant Cutaneous T-Cell LymphomaYuto Takahashi, Akihiro Kitadate, Sayaka Iwama, et al.
Oncotarget|December 10, 2016
Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphomaFumito Abe, Akihiro Kitadate, Sho Ikeda, et al.
Pageof 4